Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France (SISTOLA)

AstraZeneca

Status: Completed

Conditions: Heart Failure; Cohort Study

Treatments: Drug: Candesartan

Study type: Observational

Funder types: Industry

Identifiers

NCT00679640

NIS-CFR-ATA-2007/1

Details and patient eligibility

About

The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution

Enrollment: 450 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure

Exclusion criteria

• patients included in a clinical trial the last 30 days before consultation
• patients unable to answer the questions for linguistic or cognitive reasons
• patients who will be difficult to follow during the one year study

Trial design

450 participants in 1 patient group

1

Description:

Outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure

Treatment:

Drug: Candesartan